Cardiomyopathy with Mitochondrial Damage Associated with Nucleoside Reverse-Transcriptase Inhibitors
Authors:
- Fenneke C.P. FrerichsFFFenneke C.P. Frerichs
- Koert P. DingemansKDKoert P. Dingemans
- Kees BrinkmanKBKees Brinkman
- 5 December 2002
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 347 (23) , 1895-1896
Abstract
In July 2000, a 58-year-old man infected with the human immunodeficiency virus (HIV) began treatment with highly active antiretroviral therapy, which initially consisted of zidovudine, lamivudine, and ritonavir-boosted indinavir. After three months, a buffalo hump, anemia, and proximal muscle weakness developed, and the regimen was therefore switched to stavudine, lamivudine, and nevirapine. Because of pain in his legs, stavudine was replaced with abacavir three months later.Keywords
This publication has 3 references indexed in Scilit:
- Cardiomyopathy in AIDS: A pathophysiological perspectiveProgress in Cardiovascular Diseases, 2000
- RETRACTED: Incidence of Dilated Cardiomyopathy and Detection of HIV in Myocardial Cells of HIV-Positive PatientsNew England Journal of Medicine, 1998
- Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virusThe Journal of Pediatrics, 1995